Sw. Borron et al., MARKEDLY ALTERED COLCHICINE KINETICS IN A FATAL INTOXICATION - EXAMINATION OF CONTRIBUTING FACTORS, Human & experimental toxicology, 15(11), 1996, pp. 885-890
1 Colchicine poisoning, which is relatively rare, is associated with s
ignificant morbidity and mortality. Whilst a new treatment modality, i
n the form of colchicine-specific Fab fragments is on the horizon, cur
rently available therapy is largely supportive. 2 The elimination of c
olchicine occurs primarily by hepatic metabolism, following a first-or
der process, with significant enterohepatic circulation. Renal extract
ion is responsible for approximately 20% of colchicine elimination. 3
We report a case of colchicine intoxication, complicated by the presen
ce of co-ingestants, in which serum colchicine concentrations remained
quasi-constant over the 3 days of the patient's survival, consistent
with marked alterations both in metabolism and excretion. The initial
presentation was relatively benign but the subsequent course was one o
f severe colchicine poisoning, resulting in death. 4 Severe colchicine
toxicity appears to have resulted in a vicious cycle of progressive o
rgan dysfunction and impaired elimination. 5 Josamycin, one of the co-
ingestants and an inhibitor of P-glycoprotein, the membrane pump respo
nsible for multidrug resistance, may have played a significant role in
impeding the cellular and biliary elimination of colchicine. Go-inges
ted opioid and anticholinergic compounds may have altered colchicine a
bsorption and gastrointestinal transit. 6 This case serves as a remind
er of the need for attention to co-ingested drugs, tb early aggressive
therapy, and if available, to consideration of immunotherapy.